Interim findings from the DESTINY Breast09 trial indicate promising efficacy for trastuzumab deruxtecan in...
HER2
In a recent case study presented by Dr. Jacob Sands, the complexities of treating...
New research indicates that some patients with early-stage breast cancer may not require sentinel...
Bayer AG has received approval from the US Food and Drug Administration (FDA) for...
A novel radioimmunotherapy regimen has demonstrated the potential to effectively treat human epidermal growth...
